Axial Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.axialtx.com
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease
Recruiting
- Conditions
- Parkinsons Disease (PD)
- First Posted Date
- 2025-09-16
- Last Posted Date
- 2025-09-16
- Lead Sponsor
- Axial Therapeutics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT07175922
- Locations
- 🇳🇱
Center for Human Drug Research, Leiden, Netherlands
AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)
Phase 2
Active, not recruiting
- Conditions
- Autism Spectrum Disorder (ASD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Axial Therapeutics, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT04895215
- Locations
- 🇺🇸
Harmonex Neuroscience Research, Dothan, Alabama, United States
🇺🇸Southwestern Autism Research and Resource Center, Phoenix, Arizona, United States
🇺🇸University of Arizona, Tucson, Arizona, United States
News
No news found